Alnylam Pharmaceuticals, Inc. ALNY
NasdaqGS β’ Real-Time Technical Indicators & Signals β’ Currency: USD
Automated Algorithmic Diagnosis
REAL-TIMEAlgorithmic Technical Summary for Alnylam Pharmaceuticals, Inc. (ALNY): As of current market pricing, ALNY is trading at $147.82 (-1.58 (-1.06%)). Technical indicator diagnostics show a 14-day Relative Strength Index (RSI) of 27.94, indicating a Oversold condition. The daily MACD (Moving Average Convergence Divergence) indicator is currently registered at -18.25 versus the signal line of -18.64, giving a histogram reading of +0.4 (Bullish Momentum). From a structural trend perspective, ALNY is trading -45.3% below its 200-day exponential moving average ($270.23), classifying the prevailing institutional trend bias as Bullish Trend Structure.
ALNY Price & Trend Overlay (Last 90 Days)
Looking to buy or trade Alnylam Pharmaceuticals, Inc. (ALNY)?
Trade TSX and US stocks with low commissions on Questrade. Open a TFSA, RRSP, or Margin account and receive a $50 cash reward with promo code 386513194498114.
Technical Indicators & Market Metrics Table
| Indicator / Metric | Current Value | Technical Status | Market Interpretation |
|---|---|---|---|
| RSI (14) | 27.94 | Oversold | RSI at 27.94 is in extreme oversold territory (< 30), signaling heavy selling exhaustion and a potential mean-reversion rebound. |
| MACD Line (12, 26) | -18.25 | Bullish Momentum | Signal line: -18.64, Histogram: 0.4 |
| 20-Day EMA | $171.6 | Bearish | Short-term momentum guide. Price is trading under $171.6. |
| 50-Day EMA | $200.35 | Bearish | Medium-term trend indicator. Institutional support/resistance band. |
| 200-Day EMA | $270.23 | Long-Term Downtrend | Major institutional baseline. Distance to 200 EMA: -45.3%. |
| Average True Range (ATR 14) | $9.7 | Volatility | Expected average daily dollar price fluctuation. |
| 52-Week Range | $146.51 - $479.79 | Annual Range | Current price is $147.82 within the 52-week envelope. |
| Volume vs 30d Avg | 2.15M / 2.71M | Liquidity | Market Cap: 19.80B β’ P/E Ratio: 7.5 |
Technical Setups From Our Latest Scan
Stocks currently flagged by our RSI, MACD and EMA scan. See the full lists: oversold stocks Β· overbought stocks Β· MACD crossovers Β· Golden Cross Β· EMA screener Β· TSX scanner.
Frequently Asked Questions about Alnylam Pharmaceuticals, Inc. (ALNY)
Q: What is ALNY's RSI (Relative Strength Index) today?
As of today, Alnylam Pharmaceuticals, Inc. (ALNY) has a 14-day RSI of 27.94. This indicates a Oversold condition. Traders use RSI readings below 30 to identify oversold conditions and readings above 70 to identify overbought conditions.
Q: Is ALNY's MACD indicator bullish or bearish?
The daily MACD line for ALNY is currently -18.25 compared to its 9-day signal line of -18.64, generating a histogram difference of +0.4. This translates to a Bullish Momentum signal.
Q: Where is ALNY trading relative to its 200-day EMA?
ALNY is currently trading at $147.82, which is -45.3% below its 200-day exponential moving average of $270.23. Staying above the 200 EMA is considered a primary benchmark for institutional bull market trends.
Q: What are key support and resistance levels for ALNY?
Immediate support sits around the 20-day EMA ($171.6) and recent 20-day swing low ($147.82). Immediate resistance is marked near the 20-day high ($232.40) and the 52-week high of $479.79.